These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8581422)

  • 1. An alternate synthesis of the Tat-antagonist 7-chloro-N-methyl-5-(1H-pyrrol-2-yl)-3H-1,4-benzodiazepin-2-amine.
    Maehr H; Zenchoff G; Coffen DL
    Bioorg Med Chem; 1995 Apr; 3(4):391-5. PubMed ID: 8581422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of human immunodeficiency virus type 1 Tat-dependent activation of translation in Xenopus oocytes by the benzodiazepine Ro24-7429 requires trans-activation response element loop sequences.
    Braddock M; Cannon P; Muckenthaler M; Kingsman AJ; Kingsman SM
    J Virol; 1994 Jan; 68(1):25-33. PubMed ID: 8254735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2-Glycineamide-5-chlorophenyl 2-pyrryl ketone, a non-benzodiazepin Tat antagonist, is effective against acute and chronic HIV-1 infections in vitro.
    Kira T; Hashimoto K; Baba M; Okamoto T; Shigeta S
    Antiviral Res; 1996 Oct; 32(2):55-62. PubMed ID: 8891164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery and characterization of an HIV-1 Tat antagonist.
    Hsu MC; Schutt AD; Holly M; Slice LW; Sherman MI; Richman DD; Potash MJ; Volsky DJ
    Biochem Soc Trans; 1992 May; 20(2):525-31. PubMed ID: 1397654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of HIV replication in acute and chronic infections in vitro by a Tat antagonist.
    Hsu MC; Schutt AD; Holly M; Slice LW; Sherman MI; Richman DD; Potash MJ; Volsky DJ
    Science; 1991 Dec; 254(5039):1799-802. PubMed ID: 1763331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of type 1 human immunodeficiency virus replication by a tat antagonist to which the virus remains sensitive after prolonged exposure in vitro.
    Hsu MC; Dhingra U; Earley JV; Holly M; Keith D; Nalin CM; Richou AR; Schutt AD; Tam SY; Potash MJ
    Proc Natl Acad Sci U S A; 1993 Jul; 90(14):6395-9. PubMed ID: 8341644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tat-independent replication of human immunodeficiency viruses.
    Luznik L; Kraus G; Guatelli J; Richman D; Wong-Staal F
    J Clin Invest; 1995 Jan; 95(1):328-32. PubMed ID: 7814633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An inhibitor of the Tat/TAR RNA interaction that effectively suppresses HIV-1 replication.
    Hamy F; Felder ER; Heizmann G; Lazdins J; Aboul-ela F; Varani G; Karn J; Klimkait T
    Proc Natl Acad Sci U S A; 1997 Apr; 94(8):3548-53. PubMed ID: 9108013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effect of tumor necrosis factor-alpha and herpes simplex virus type 1 on the Tat-targeted inhibition of human immunodeficiency virus type 1 replication.
    Popik W; Pitha PM
    Virology; 1994 Aug; 202(2):521-9. PubMed ID: 8030218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Keto/enol epoxy steroids as HIV-1 Tat inhibitors: structure-activity relationships and pharmacophore localization.
    Michne WF; Schroeder JD; Bailey TR; Neumann HC; Cooke D; Young DC; Hughes JV; Kingsley SD; Ryan KA; Putz HS
    J Med Chem; 1995 Aug; 38(17):3197-206. PubMed ID: 7650672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of tat-mediated HIV-1-LTR transactivation and virus replication by sulfhydryl compounds with chelating properties.
    Demirhan I; Chandra A; Sarin PS; Hasselmayer O; Hofmann D; Chandra P
    Anticancer Res; 2000; 20(4):2513-7. PubMed ID: 10953320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-Tat MTT assay: a novel anti-HIV drug screening system using the viral regulatory network of replication.
    Kira T; Merin JP; Baba M; Shigeta S; Okamoto T
    AIDS Res Hum Retroviruses; 1995 Nov; 11(11):1359-66. PubMed ID: 8573393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A second target for the peptoid Tat/transactivation response element inhibitor CGP64222: inhibition of human immunodeficiency virus replication by blocking CXC-chemokine receptor 4-mediated virus entry.
    Daelemans D; Schols D; Witvrouw M; Pannecouque C; Hatse S; van Dooren S; Hamy F; Klimkait T; de Clercq E; VanDamme AM
    Mol Pharmacol; 2000 Jan; 57(1):116-24. PubMed ID: 10617686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and anti-HIV-1 activity of 4,5,6,7-tetrahydro-5-methylimidazo-[4,5,1-jk][1,4]benzodiazepin- 2(1H)-one (TlBO) derivatives. 4.
    Ho W; Kukla MJ; Breslin HJ; Ludovici DW; Grous PP; Diamond CJ; Miranda M; Rodgers JD; Ho CY; De Clercq E
    J Med Chem; 1995 Mar; 38(5):794-802. PubMed ID: 7877144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions between HIV-1 and cytomegalovirus in human osteosarcoma cells carrying both viruses.
    Margalith M; Medina DJ; Hsiung GD; Smith BR; D'Aquila RT; Kaplan JC; Bechtel L; Wang MZ; Skolnik PR; Hirsch MS
    AIDS Res Hum Retroviruses; 1993 Jun; 9(6):519-27. PubMed ID: 8394095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of the RNA-dependent transactivation and replication of human immunodeficiency virus type 1 by a fluoroquinoline derivative K-37.
    Okamoto H; Cujec TP; Okamoto M; Peterlin BM; Baba M; Okamoto T
    Virology; 2000 Jul; 272(2):402-8. PubMed ID: 10873784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neomycin B-arginine conjugate, a novel HIV-1 Tat antagonist: synthesis and anti-HIV activities.
    Litovchick A; Lapidot A; Eisenstein M; Kalinkovich A; Borkow G
    Biochemistry; 2001 Dec; 40(51):15612-23. PubMed ID: 11747436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Turnabout on AIDS drug.
    Science; 1992 Jan; 255(5041):154. PubMed ID: 1553539
    [No Abstract]   [Full Text] [Related]  

  • 19. Cooperative inhibition of NF-kappa B and Tat-induced superactivation of human immunodeficiency virus type 1 long terminal repeat.
    Biswas DK; Ahlers CM; Dezube BJ; Pardee AB
    Proc Natl Acad Sci U S A; 1993 Dec; 90(23):11044-8. PubMed ID: 8248210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterocycles with a benzothiadiazepine moiety. 5. Derivatives of pyrrolo[2,1-d][1,2,5]benzothiadiazepine, a novel tricyclic ring.
    Di Santo R; Costi R; Artico M; Massa S
    Farmaco; 1997; 52(6-7):375-8. PubMed ID: 9372588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.